New Owner
Momenta Pharmaceuticals - Virdante Pharmaceuticals
Momenta Pharmaceuticals acquires Virdante Pharmaceuticals
Announced: December 05, 2011
Type: Acquisition
Status: Pending
Amount: $ 51,500,000